Medical Biobanks Market To Reach $27.54bn In 2020, According To New Visiongain Data

06 September 2018
Pharma

A report published by visiongain forecasts the worldwide medical biobanking industry will achieve revenues of $27.54 billion in 2020. That sales prediction and others appear in Biobanking Market Forecasts 2016-2026: Discover Prospects for Medical Research and Therapeutic Uses, Including Human Tissues, Fluids and Stem Cells. In April 2016 that updated study appeared.

Visiongain is a business information publisher and consultancy in London, UK. Its purpose is to help organisations understand industries and markets in healthcare and other fields, especially their commercial prospects.

The biobanking market will expand its overall revenues at a CAGR of 9.5% between 2015 and 2026, the new study predicts. Biobanking holds high commercial potential, serving important needs in pharmaceutical research and development, as well as basic medical research. In 2015 biobanks for research purposes formed the most lucrative part of that industry, accounting for 77.1% of the overall world market. The study shows that segment will show strong revenue expansion from 2015 to 2026.

That report’s author said: “With the ever increasing need for novel therapies and the shift towards precision medicine, high quality biobanking samples are in great demand. To meet demand, those in the biobanking industry will have to move towards standardisation and harmonisation, as well as planning ahead towards long-term financial sustainability. Another important factor will be increasing public awareness to facilitate participation, as sample donation is critical to the success of biobanking.”

Visiongain’s updated investigation shows revenue forecasts to 2026 at world market, submarket and national level. It forecasts biobanking for research and for therapeutic uses in human medicine. It also forecasts the numbers of samples stored for those two uses.

That report predicts revenues to 2026 for the following subsectors of biobanking for research:

• Human tissues (further divided to commercial and public sectors)
• Stem cells
• Other biological samples (e.g. DNA, RNA, body fluids).

The study also predicts revenues to 2026 for the following segments of biobanking for therapeutic uses:

• Umbilical cord stem cell banking
• Adult stem cell banking.

Furthermore the work analyses 12 leading national markets for biobanking, providing revenue forecasts to 2026 for each:

• The US
• Japan
• Germany, France, the UK, Italy, Spain and the Netherlands
• Brazil, Russia, India and China.

Visiongain’s survey examines leading biorepositories and related companies. That work also discusses systems, software, consumables and services used by biobanks. That 248 page report gives 72 tables, 74 charts and two interviews with authorities in that field.

Biobanking Market Forecasts 2016-2026: Discover Prospects for Medical Research and Therapeutic Uses, Including Human Tissues, Fluids and Stem Cells adds to visiongain’s analytical portfolio on industries and markets in healthcare. Those reports cover pharmaceuticals, medical devices, diagnostics and outsourced services.

Recent News

Visiongain Publishes Nasal Drug Delivery Technology Market Report 2022-2032

The nasal drug delivery market will expand rapidly due to rising patient preference for nasal medication delivery due to ease of administration and efficacy, increased self-administration practises, and increased demand for home healthcare equipment.

18 January 2022

Read

Visiongain Publishes Deep Frozen Packaging Logistics Market Report 2022-2032

The desire for various types of medications to assist combat a growing number of chronic diseases & lifestyle-related ailments is fuelling the overall deep freeze packaging logistics market demand.

14 January 2022

Read

Visiongain Publishes Pre-Filled Syringes Market Report 2022-2032

With COVID-19 pandemic, the prefilled syringes business has witnessed a significant growth. Since the outbreak of the pandemic, global market players involved in the development of the prefilled syringes market across the globe have increased their investment in raw materials and resources owing to the rise in demand for home based healthcare services.

11 January 2022

Read

Visiongain Publishes Single-use Bioprocessing Probes & Sensors Market Report 2022-2032

To promote their organic revenue growth and market presence, the top companies are pursuing different strategic initiatives such as OEM collaborations and new product development with better technological intricacy.

05 January 2022

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever